EP3638669A1 - Dérivés de pyrrolopyridine substitués - Google Patents
Dérivés de pyrrolopyridine substituésInfo
- Publication number
- EP3638669A1 EP3638669A1 EP18728901.2A EP18728901A EP3638669A1 EP 3638669 A1 EP3638669 A1 EP 3638669A1 EP 18728901 A EP18728901 A EP 18728901A EP 3638669 A1 EP3638669 A1 EP 3638669A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- pyridin
- pyrrolo
- alkyl
- oxy
- urea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17175861 | 2017-06-13 | ||
PCT/EP2018/065036 WO2018228920A1 (fr) | 2017-06-13 | 2018-06-07 | Dérivés de pyrrolopyridine substitués |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3638669A1 true EP3638669A1 (fr) | 2020-04-22 |
Family
ID=59055146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18728901.2A Withdrawn EP3638669A1 (fr) | 2017-06-13 | 2018-06-07 | Dérivés de pyrrolopyridine substitués |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3638669A1 (fr) |
CA (1) | CA3066859A1 (fr) |
WO (1) | WO2018228920A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020092528A1 (fr) | 2018-10-31 | 2020-05-07 | Gilead Sciences, Inc. | Composés 6-azabenzimidazole substitués ayant une activité inhibitrice de hpk1 |
US11203591B2 (en) | 2018-10-31 | 2021-12-21 | Gilead Sciences, Inc. | Substituted 6-azabenzimidazole compounds |
WO2020193511A1 (fr) | 2019-03-26 | 2020-10-01 | Janssen Pharmaceutica Nv | Inhibiteurs de hpk1 |
US20220169644A1 (en) | 2019-03-26 | 2022-06-02 | Janssen Pharmaceutica Nv | Bicyclic hpk1 inhibitors |
EP3972695A1 (fr) | 2019-05-23 | 2022-03-30 | Gilead Sciences, Inc. | Exo-méthylène-oxindoles substitués qui sont des inhibiteurs de hpk1/map4k1 |
WO2021226547A2 (fr) * | 2020-05-08 | 2021-11-11 | Halia Therapeutics, Inc. | Inhibition ciblée de nek7 pour la modulation de l'inflammasome nlrp3 |
WO2022159835A1 (fr) * | 2021-01-25 | 2022-07-28 | Halia Therapeutics, Inc. | Inhibiteurs de nek7 |
WO2022226182A1 (fr) * | 2021-04-22 | 2022-10-27 | Halia Therapeutics, Inc. | Inhibiteurs de nek7 |
WO2022268520A1 (fr) * | 2021-06-21 | 2022-12-29 | Bayer Aktiengesellschaft | Utilisation de pyrrolidinones substituées ou de leurs sels pour augmenter la tolérance au stress des plantes |
CN117693503A (zh) | 2021-07-20 | 2024-03-12 | 阿斯利康(瑞典)有限公司 | 作为hpk1抑制剂用于治疗癌症的经取代的吡嗪-2-甲酰胺 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10357510A1 (de) | 2003-12-09 | 2005-07-07 | Bayer Healthcare Ag | Heteroarylsubstituierte Benzole |
US7439246B2 (en) * | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
WO2006014325A2 (fr) | 2004-07-02 | 2006-02-09 | Exelixis, Inc. | Modulateurs de c-met et leur methode d'utilisation |
US8299252B2 (en) * | 2005-08-05 | 2012-10-30 | Chugai Seiyaku Kabushiki Kaisha | Pyrazolopyridine and pyrrolopyridine multikinase inhibitors |
EP2001880A2 (fr) | 2006-03-07 | 2008-12-17 | Array Biopharma, Inc. | Derives heterobicycliques de pyrazole et methodes d'utilisation |
AU2014361798B2 (en) | 2013-12-13 | 2020-06-11 | Dana-Farber Cancer Institute, Inc. | Methods to treat lymphoplasmacytic lymphoma |
AR104020A1 (es) | 2015-06-04 | 2017-06-21 | Kura Oncology Inc | Métodos y composiciones para inhibir la interacción de menina con proteínas mill |
RS61919B1 (sr) | 2015-06-25 | 2021-06-30 | Univ Health Network | Inhibitori hpk1 i postupci za njihovo korišćenje |
KR102507967B1 (ko) | 2016-09-09 | 2023-03-09 | 인사이트 코포레이션 | Hpk1 조절제로서의 피라졸로피리딘 유도체 및 암을 치료하기 위한 이의 용도 |
WO2018049214A1 (fr) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Dérivés de pyrazolopyridine comme modulateurs de hpk1 et leurs utilisations pour le traitement du cancer |
WO2018049191A1 (fr) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Dérivés de pyrazolopyridone en tant que modulateurs de hpk1 et leurs utilisations pour le traitement du cancer |
US20180072741A1 (en) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Pyrazolopyrimidine compounds and uses thereof |
-
2018
- 2018-06-07 CA CA3066859A patent/CA3066859A1/fr not_active Abandoned
- 2018-06-07 WO PCT/EP2018/065036 patent/WO2018228920A1/fr unknown
- 2018-06-07 EP EP18728901.2A patent/EP3638669A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2018228920A1 (fr) | 2018-12-20 |
CA3066859A1 (fr) | 2018-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3638669A1 (fr) | Dérivés de pyrrolopyridine substitués | |
AU2018217860B2 (en) | 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer | |
US11427578B1 (en) | Substituted pyrrolopyridine-derivatives | |
EP3638670B1 (fr) | Dérivés de pyrrolopyridine substitués utilisés en tant que modulateurs de map4k1 pour le traitement de maladies cancéreuses | |
US11591311B2 (en) | 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides | |
WO2018228925A1 (fr) | Dérivés de pyrrolopyridine substitués | |
CA3082856A1 (fr) | 3-oxo-2,3-dihydropyridazine-4-carboxamides substitues par du soufre | |
WO2019101641A1 (fr) | 2-hetarylpyrimidine-4-carboxamides à utiliser en tant qu'anatgonistes de récepteur d'hydrocarbure aryle | |
US20220047603A1 (en) | Substituted pyrrolopyridine-derivatives | |
CA3082858A1 (fr) | 2-phenylpyrimidine-4-carboxamides a utiliser en tant qu'inhibiteurs d'ahr | |
WO2021074279A1 (fr) | Inhibiteurs de map4k1 tricycliques spiro fusionnés | |
US20230113037A1 (en) | [1,2,4]triazolo[1,5-c]quinazolin-5-amines | |
WO2021249913A1 (fr) | Dérivés de 2'-(quinolin-3-yl)-5',6'-dihydrospiro[azétidine-3,4'-pyrrolo[1,2-b]pyrazole]-1-carboxylate et des composés apparentés servant d'inhibiteurs de map4k1 (hpk1) pour le traitement du cancer | |
WO2019081343A1 (fr) | Nouveaux dérivés de pyrazolo-pyrrolo-pyrimidine-dione utilisés en tant qu'inhibiteurs de p2x3 | |
WO2017102091A1 (fr) | Composés hétéroarylbenzimidazole | |
WO2022167627A1 (fr) | Inhibiteurs de map4k1 | |
WO2022029063A1 (fr) | Pyrido[1,2,4]triazolo[1,5-c]pyrimidin-5-amines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200113 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20210716 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20211127 |